Mead Johnson Nutrition Reaches New 52-Week High (MJN)

NEW YORK ( TheStreet) -- Mead Johnson Nutrition Company (NYSE: MJN) hit a new 52-week high Wednesday as it is currently trading at $80.74, above its previous 52-week high of $80.51 with 51,178 shares traded as of 10 a.m. ET. Average volume has been 2.2 million shares over the past 30 days.

Mead Johnson Nutrition has a market cap of $14.4 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 16.4% year to date as of the close of trading on Tuesday.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children's nutritional products, and other nutritional products in Asia, Europe, Latin America, and North America. The company has a P/E ratio of 32.4, above the average food & beverage industry P/E ratio of 28 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Mead Johnson Nutrition as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, good cash flow from operations and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full Mead Johnson Nutrition Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

McCormick in $4.2 Billion Play for Reckitt Benckiser's Food Division

Reckitt Wrecked By Petya Virus

Reckitt Benckiser Says Petya Cyber Attack Will Slam Q2 Revenues

Reckitt to Close $18 Billion Mead Johnson Takeover Deal June 15